Emergence of plasmid-mediated colistin resistance (MCR-1) among Escherichia coli isolated from South African patients

South African Medical Journal

Volumn 106, Issue 5, 2016, Pages 449-450

  Coetzee, Jennifer ^a   Corcoran, Craig ^a   Prentice, Elizabeth ^a   Moodley, Mischka ^b   Mendelson, Marc ^c   Poirel, Laurent ^d   Nordmann, Patricia ^d   Brink, Adrian J ^e  

^a Departments of Clinical Microbiology and Molecular Sciences at the Ampath Reference Laboratory   (South Africa)

^b Ampath National Laboratory Services   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF FRIBOURG   (Switzerland)

^e MILPARK HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; ENTEROBACTERIACEAE; ESCHERICHIA COLI INFECTION; FEMALE; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PLASMID; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SOUTH AFRICAN; ANIMAL; DRUG EFFECTS; ESCHERICHIA COLI; GENETICS; MEAT; MICROBIOLOGY; PUBLIC HEALTH; SOUTH AFRICA;

ADULT; AGED; ANIMALS; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; MALE; MEAT; MIDDLE AGED; PLASMIDS; PUBLIC HEALTH; SOUTH AFRICA;

EID: 84964720813     PISSN: 02569574     EISSN: 20785135     Source Type: Journal    
DOI: 10.7196/SAMJ.2016.v106i5.10710     Document Type: Article

References (8)

1. The Center for Disease Dynamics, Economics and Policy. The State of the World’s Antibiotics, 2015. Washington DC: The Centre for Disease Dynamics, Economics and Policy, 2015. http://cddep.org/publications/state_worlds_antibiotics_2015#sthash.S3a3ME0o.dpbs (accessed 19 February 2016).
2. Brink AJ, Coetzee J, Corcoran C, et al. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Micro 2013;51(1):369-372. DOI:10.1128/JCM.02234-12
3. Mendelson M, Matsoso MB. A global call for action to combat antimicrobial resistance: Can we get it right this time? S Afr Med J 2014;104(7):478-479. DOI:10.7196/SAMJ.8534
4. Jayol A, Nordmann P, Brink AJ, et al. Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system. Antimicrob Agents Chemother 2015;59(5):2780-2784. DOI:10.1128/AAC.05055-14
5. Liu Y-Y, Wang T, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect Dis 2016;16(2):161-168. DOI:10.1016/S1473-3099(15)00424-7
6. Arcilla MS, van Hattem JM, Matamoros S, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 2016;16(2):147-149. DOI:10.1016/S1473-3099(15)00541-1
7. Poirel L, Kieffer N, Liassine N, et al. Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli. Lancet Infect Dis 2016, in press.
8. Gerber D. Colistin resistance in E. coli in broiler operations in South Africa. In: V-Tech Report, 11 January 2016. Johannesburg: V-Tech Pty (Ltd), 2016.